PRICE T ROWE ASSOCIATES INC /MD/ - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 121 filers reported holding IMMUNOVANT INC in Q4 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$28,027
+7454.4%
730,042
+3638.4%
0.00%
Q2 2023$371
-94.6%
19,528
-95.6%
0.00%
-100.0%
Q1 2023$6,875
+40.3%
443,204
+60.6%
0.00%0.0%
Q4 2022$4,899
-97.5%
275,999
+1116.9%
0.00%
Q3 2021$197,000
+5.9%
22,680
+28.8%
0.00%
Q2 2021$186,000
-32.9%
17,603
+2.0%
0.00%
Q1 2021$277,000
-97.9%
17,258
-94.0%
0.00%
-100.0%
Q4 2020$13,395,000
+85.2%
289,988
+41.1%
0.00%0.0%
Q3 2020$7,233,000205,5500.00%
Other shareholders
IMMUNOVANT INC shareholders Q4 2021
NameSharesValueWeighting ↓
Alpine Global Management, LLC 4,448,017$17,347,0004.39%
Deep Track Capital, LP 9,455,000$36,875,0002.42%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 233$60,000,0000.63%
Octagon Capital Advisors LP 579,061$2,258,0000.60%
Eventide Asset Management 5,372,512$20,953,0000.45%
WITTENBERG INVESTMENT MANAGEMENT, INC. 174,000$679,0000.29%
Frazier Life Sciences Management, L.P. 585,759$2,284,0000.22%
BCK CAPITAL MANAGEMENT LP 54,293$212,0000.16%
PLATINUM INVESTMENT MANAGEMENT LTD 777,590$3,033,0000.12%
Bridgefront Capital, LLC 15,649$61,0000.07%
View complete list of IMMUNOVANT INC shareholders